Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | OPRM1 | P35372 | 12/20 | 0.85 |
| ▸ | OPRD1 | P41143 | 5/20 | 0.85 |
| ▸ | OPRK1 | P41145 | 5/20 | 0.85 |
| ▸ | SLC22A1 | O15245 | 1/20 | 0.85 |
| ▸ | NR1I2 | O75469 | 1/20 | 0.85 |
| ▸ | ABCB1 | P08183 | 1/20 | 0.85 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.85 |
| ▸ | DRD2 | P14416 | 1/20 | 0.85 |
| ▸ | ADRA2B | P18089 | 1/20 | 0.85 |
| ▸ | ADRA2C | P18825 | 1/20 | 0.85 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.85 |
| ▸ | MAOA | P21397 | 1/20 | 0.85 |
| ▸ | DRD4 | P21917 | 1/20 | 0.85 |
| ▸ | MAOB | P27338 | 1/20 | 0.85 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.85 |
| ▸ | HRH1 | P35367 | 1/20 | 0.85 |
| ▸ | ADRA1B | P35368 | 1/20 | 0.85 |
| ▸ | DRD3 | P35462 | 1/20 | 0.85 |
| ▸ | CHRNA4 | P43681 | 1/20 | 0.85 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.85 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13284174 | 0.96 | OPRM1 (0.85) | OPRM1OPRD1OPRK1SLC22A1NR1I2 | |
| Fentanyl SCHEMBL27642639 | 0.92 | OPRM1 (0.95) | OPRM1OPRD1OPRK1SLC22A1NR1I2 | |
| Fentanyl SCHEMBL916599 | 0.92 | OPRM1 (1.00) | OPRM1OPRD1OPRK1SLC22A1NR1I2 | |
| Fentanyl SCHEMBL8804 | 0.92 | OPRM1 (1.00) | OPRM1OPRD1OPRK1SLC22A1NR1I2 | |
| SCHEMBL18623766 | 0.91 | OPRM1 (0.75) | OPRM1OPRD1OPRK1SLC22A1NR1I2 | |
| Fentanyl SCHEMBL28383546 | 0.91 | OPRM1 (0.98) | OPRM1OPRD1OPRK1SLC22A1NR1I2 | |
| Fentanyl SCHEMBL4321837 | 0.91 | OPRM1 (0.98) | OPRM1OPRD1OPRK1SLC22A1NR1I2 | |
| Fentanyl SCHEMBL22637301 | 0.91 | OPRM1 (0.98) | OPRM1OPRD1OPRK1SLC22A1NR1I2 | |
| Fentanyl SCHEMBL18249370 | 0.91 | OPRM1 (0.98) | OPRM1OPRD1OPRK1SLC22A1NR1I2 | |
| Fentanyl SCHEMBL4324385 | 0.91 | OPRM1 (0.98) | OPRM1OPRD1OPRK1SLC22A1NR1I2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 118 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025111482-A1 | COMPLEXING AGENT SALT FORMULATIONS OF PHARMACEUTICAL COMPOUNDS AT LOW STOICHIOMETRIC RATIOS | BEXSON BIOMEDICAL, INC. (US) | 2025-05-30 | — | — | WO | claimed |
| WO-2024172892-A1 | PLASMONIC NANOPARTICLE PLATFORM FOR ANALYTE DETECTION | Zymeron Corporation (US) | 2024-08-22 | — | — | WO | claimed |
| WO-2024173482-A2 | COMPOSITIONS AND METHODS RELATED TO APTAMER-BASED SENSORS | NORTH CAROLINA STATE UNIVERSITY (US) | 2024-08-22 | — | — | WO | claimed |
| US-11579110-B2 | Aptamer-based sensors for detection of fentanyl opioids | THE FLORIDA INTERNATIONAL UNIVERSITY BOARD OF TRUSTEES (US) | 2023-02-14 | — | — | US | claimed |
| US-20220291163-A1 | APTAMER-BASED SENSORS FOR DETECTION OF FENTANYL OPIOIDS | THE FLORIDA INTERNATIONAL UNIVERSITY BOARD OF TRUSTEES (US) | 2022-09-15 | — | — | US | claimed |
| US-11408850-B2 | Aptamer-based sensors for detection of fentanyl opioids | THE FLORIDA INTERNATIONAL UNIVERSITY BOARD OF TRUSTEES (US) | 2022-08-09 | — | — | US | claimed |
| EP-3560484-A1 | ABUSE-DETERRENT PHARMACEUTICAL COMPOSITION | G.L. Pharma GmbH (AT) | 2019-10-30 | — | — | EP | claimed |
| EP-3423034-B1 | ABUSE-DETERRENT PHARMACEUTICAL COMPOSITION | G L PHARMA GMBH (AT) | 2019-07-10 | — | — | EP | claimed |
| EP-3423034-A1 | ABUSE-DETERRENT PHARMACEUTICAL COMPOSITION | G.L. Pharma GmbH (AT) | 2019-01-09 | — | — | EP | claimed |
| EP-3210596-A1 | ABUSE-DETERRENT PHARMACEUTICAL COMPOSITION | G.L. Pharma GmbH (AT) | 2017-08-30 | — | — | EP | claimed |
| EP-3129028-A1 | PHARMACEUTICAL COMPOSITIONS | Charleston Laboratories, Inc. (US) | 2017-02-15 | — | — | EP | claimed |
| US-20150313846-A1 | PROLONGED-RELEASE MULTIMICROPARTICULATE ORAL PHARMACEUTICAL FORM | FLAMEL IRELAND LIMITED (IE) | 2015-11-05 | — | — | US | claimed |
| WO-2015157738-A1 | PHARMACEUTICAL COMPOSITIONS | CHARLESTON LABORATORIES, INC. (US) | 2015-10-15 | — | — | WO | claimed |
| US-9023400-B2 | Prolonged-release multimicroparticulate oral pharmaceutical form | FLAMEL TECHNOLOGIES (FR) | 2015-05-05 | — | — | US | claimed |
| US-8652529-B2 | Anti-misuse microparticulate oral pharmaceutical form | FLAMEL TECHNOLOGIES (FR) | 2014-02-18 | — | — | US | claimed |
| US-8445023-B2 | Anti-misuse microparticulate oral pharmaceutical form | FLAMEL TECHNOLOGIES (FR) | 2013-05-21 | — | — | US | claimed |
| US-20100092553-A1 | ANTI-MISUSE MICROPARTICULATE ORAL PHARMACEUTICAL FORM | FLAMEL TECHNOLOGIES (FR) | 2010-04-15 | — | — | US | claimed |
| US-20070224129-A1 | Anti-misuse microparticulate oral pharmaceutical form | FLAMEL TECHNOLOGIES, INC. (FR) | 2007-09-27 | — | — | US | claimed |
| US-20260086062-A1 | IMMOBILIZATION STRATEGIES FOR ENHANCING SENSITIVITY OF ELECTROCHEMICAL APTAMER-BASED SENSORS | THE FLORIDA INTERNATIONAL UNIVERSITY BOARD OF TRUSTEES (US) | 2026-03-26 | — | — | US | disclosed |
| WO-2007093642-A2 | MICROPARTICULATE PHARMACEUTICAL FORMS RESISTANT TO IMMEDIATE RELEASE OF THE ACTIVE PRINCIPLE IN THE PRESENCE OF ALCOHOL | FLAMEL TECHNOLOGIES (FR) | 2007-08-23 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260086062-A1 | IMMOBILIZATION STRATEGIES FOR ENHANCING SENSITIVITY OF ELECTROCHEMICAL APTAMER-BASED SENSORS | EBPL, ADA, XBP1 | OPRM1 1242/4885OPRD1 2597/4885OPRK1 3579/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.